Top-News
Pharmazeutika Schweden

LIPIDOR AB Aktie

Aktie
WKN:  A2PHEZ ISIN:  SE0012558617
0,0001 €
+0,00 €
0,00%
05.06.25
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
98,88%
KGV
-0,87
Index-Zugehörigkeit
-

LIPIDOR AB News

01.07.21 - PR Newswire
Lipidor AB licence agreement grants Menarini Group company, RELIFE Srl, exclusive rights to register, promote, distribute and market two new psoriasis drug candidates for potential value of MEUR 70
Lipidor AB licence agreement grants Menarini Group company, RELIFE Srl, exclusive rights to register, promote, distribute and market two new psoriasis drug candidates for ...
01.07.21 - PR Newswire
Lipidor AB licence agreement grants Menarini Group company, RELIFE Srl, exclusive rights to register, promote, distribute and market two new psoriasis drug candidates for potential value of MEUR 70
Lipidor AB licence agreement grants Menarini Group company, RELIFE Srl, exclusive rights to register, promote, distribute and market two new psoriasis drug candidates for ...
23.04.21 - PR Newswire
Lipidor's subsidiary Emollivet takes the next step towards launch and receives funding from Vinnova
Lipidor's subsidiary Emollivet takes the next step towards launch and receives funding from Vinnova PR Newswire
23.04.21 - PR Newswire
Lipidor's subsidiary Emollivet takes the next step towards launch and receives funding from Vinnova
Lipidor's subsidiary Emollivet takes the next step towards launch and receives funding from Vinnova PR Newswire
22.04.21 - PR Newswire
Lipidor - update on the company's phase III clinical trial of drug candidate AKP02 for treatment of psoriasis
Lipidor - update on the company's phase III clinical trial of drug candidate AKP02 for treatment of psoriasis PR Newswire
22.04.21 - PR Newswire
Lipidor - update on the company's phase III clinical trial of drug candidate AKP02 for treatment of psoriasis
Lipidor - update on the company's phase III clinical trial of drug candidate AKP02 for treatment of psoriasis PR Newswire
18.01.21 - PR Newswire
Lipidor and Cannassure enter exclusive licensing agreement regarding topical medical cannabis products based on Lipidor's AKVANO® technology
Lipidor and Cannassure enter exclusive licensing agreement regarding topical medical cannabis products based on Lipidor's AKVANO® technology PR Newswire
18.01.21 - PR Newswire
Lipidor and Cannassure enter exclusive licensing agreement regarding topical medical cannabis products based on Lipidor's AKVANO® technology
Lipidor and Cannassure enter exclusive licensing agreement regarding topical medical cannabis products based on Lipidor's AKVANO® technology PR Newswire
16.12.20 - PR Newswire
Lipidor signs cooperation agreement with contract manufacturer to offer licensees the opportunity for GMP production
Lipidor signs cooperation agreement with contract manufacturer to offer licensees the opportunity for GMP production PR Newswire
16.12.20 - PR Newswire
Lipidor signs cooperation agreement with contract manufacturer to offer licensees the opportunity for GMP production
Lipidor signs cooperation agreement with contract manufacturer to offer licensees the opportunity for GMP production PR Newswire

Newssuche

Videos

newspaper
12.06.25 +2,60%
Technical Trading: Cotton Zukauf Chance
Cotton Long Typ: Turbo Open End WKN: VP6N8D Hebel: 3,80 Laufzeit: OpenEnd Einstieg: Market ... Mehr »